Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trials

Medical device clinical trials from ClinicalTrials.gov

Trial COMPLETED

Treatment of Fecal Incontinence and Chronic Constipation With Low-volume Irrigation

NCT NCT05773742

Start 2023-04-17

View Details →

Trial ACTIVE_NOT_RECRUITING

Clinical Validation of Samsung Smartwatch

NCT NCT05767593

Start 2023-04-27

View Details →

Trial RECRUITING

Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)

NCT NCT05765175

Start 2023-04-21

View Details →

Trial ACTIVE_NOT_RECRUITING

Evaluation of the Use of a Remote Monitoring and Follow-up Option for Patients With Chronic Obstructive Pulmonary Disease (BOREAL)

NCT NCT05759247

Start 2023-06-19

View Details →

Trial TERMINATED

Trapeziectomy: Internal Brace vs. Ligament Reconstruction (Prospective)

NCT NCT05753891

Start 2023-04-01

View Details →

Trial COMPLETED

Cryoprobe Versus Forceps for Transbronchial Biopsy

NCT NCT05751278

Start 2023-02-27

View Details →

Trial RECRUITING

Evaluation of Fractional Ablative Laser Treatment for Skin Conditions

NCT NCT05750901

Start 2022-11-01

View Details →

Trial COMPLETED

Comparison of DCB and DES for Severe Calcification of de Novo Lesion in Elderly CHD

NCT NCT05750771

Start 2023-02-20

View Details →

Trial RECRUITING

Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast or Lung Cancer

NCT NCT05746325

Start 2023-04-07

View Details →

Trial RECRUITING

Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal Adenocarcinomas

NCT NCT05745857

Start 2023-09-15

View Details →

Trial RECRUITING

SHAPE Test for Preoperative Risk Stratification

NCT NCT05743673

Start 2023-05-03

View Details →

Trial ACTIVE_NOT_RECRUITING

Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma

NCT NCT05743595

Start 2023-10-27

View Details →

Page 892 of 959

↑